Precision Medicine

A Roadmap for The Future

CANCERPLEX® tests the DNA changes that could be driving your cancer and identifies any therapies that have been shown to target those changes.


Precision medicine is a medical model that employs diagnostic testing for selecting appropriate and optimal therapies based on the context of a patient’s genetic profile. 



Cancer develops when genetic material (DNA) becomes damaged or changed. Some cancer-causing genetic changes are inherited, while others come from exposure to chemicals (such as those in cigarette smoke), radiation, certain microbes or other environmental factors.

As science progresses, we’re learning more about these genetic changes and finding therapies to successfully target them. In general, personalized medicine have fewer side effects than broad-based chemotherapy. They can also be more effective in stopping the spread of a cancer when other treatments have failed.

Comprehensive genomic profiling (CGP) is a type of molecular-based test to evalutate DNA from tumors. CGP can identify genomic variants specific to a tumor and provide therapeutic options based on that genomic profile. This is premise for percision medicine.


KEW understands that fighting cancer is tough. That’s why we are here to help. 

Your cancer is unique

That’s why we use your tumor sample to analyze mutations and find thrapeutic options unique to you.

Your sample is valuable

That’s why we use minimal invasive method to obtain minimum tumor sample and still has a >99% acceptance rate.

Your treatment can't wait

That’s why we promise a easy-to-read and comprehensive report in 7-10 business days.

Your trust is important

That’s why our proprietary CANCERPLEX test delivers actionable reaults 93% of the time with virtually 100% accuracy.

Reimbursement matters

That’s why we will help you minimize the financial burden. Some patients are eligible for KEW’s Financial Assistance Program. Contact us for more information.

Science is advancing

That’s why we offer cutting edge and relevant information to your oncologist.


The report contains a list of potential therapies targeting the genomic changes unique to the patient, including

FDA-approved therapies in patient’s cancer type


Clinical trials enrolling patients with the cancer type


FDA-approved therapies in other cancer types


CANCERPLEX tests somatic mutations (alterations in DNA that occurs after conception) for all solid tumors including but not limited to


Gastrointestinal (GI)

Colon, Rectal, Anal, Esophageal, Gastric, Hepatic, Biliary and Pancreatic cancers


Gynecologic (GYN) & Breast

Breast, Ovarian, Cervical, Uterine and Endometrial cancers



NSCLC, SCLC and Mesothelioma


Melanoma & Skin

Skin Basal Cell tumors and Melanomas


Genitourinary (GU)

Kidney, Prostate, Bladder and Urothelial cancers


Head & Neck

Head and Neck cancers


Step 1

Your oncologist decides if CANCERPLEX is right for you and then places the order. KEW works with your oncologist to have your tumor sample sent to our laboratory.

Step 2

KEW analyzes the DNA from your tumor sample to identify the genomic changes that are unique to your cancer.

Step 3

Within 7-10 business days from receipt of your tumor sample, KEW sends your oncologist a detailed report with potential targeted therapies either FDA-approved or in clinical trials.

Step 4

Based on your results, your oncologist can start you on a personalized treatment path.

Ask Your Oncologist To Start Your Journey Today.


How do I get the CANCERPLEX test?

The CANCERPLEX tests are ordered by your oncologist if he or she determines you are a candidate for this type of testing. Talk to your oncologist about whether this type of test is right for you.

Does CANCERPLEX test for my type of cancer?

The CANCERPLEX tests look for specific genomic changes in solid tumors. Your oncologist will determine whether CANCERPLEX would be right for your cancer.

How much does the CANCERPLEX test cost?

KEW will work with your insurance provider to get reimbursement. Depending on your coverage plan, you may be responsible for co-pays, co-insurance or a deductible. For more detailed information, please contact us at 855.225.4068.

Is the CANCERPLEX test covered by insurance?

KEW accepts most major private insurance as well as Medicare. However, we are currently not an in-network provider with all insurance plans. Call 855.225.4068 and press 1 for more information about specific policies.

Is the CANCERPLEX test covered by Medicare?

KEW accepts 100% of the Medicare allowable amount for our services. If there is a deductible, co-insurance or co-payment, you will be responsible for those amounts.

If you have supplemental insurance to Medicare, we will also bill this secondary insurer as long as the information for the insurer has been provided.

What if my insurance does not cover CANCERPLEX Testing?

The majority of patients have coverage for genetic testing with low out-of-pocket costs. KEW accepts all insurance plans; however, our status may be listed as “not in-network provider” with some insurance plans. KEW works closely with insurance providers to determine coverage and will accept the amount of coverage assigned as payment in full. Patients may be responsible for co-pay, co-insurance and/or unmet deductibles.

Will you contact my insurance company on my behalf if coverage is denied or only partially covered?

Yes, we will contact your insurance company directly and provide information to support the appeal. You may continue to receive Explanation of Benefits (EOB) during this time. Patients may be responsible for co-pay, co-insurance and/or unmet deductibles.

Will I receive a bill for the test?

Your insurer may issue an Explanation of Benefits (EOB), which is not a bill. The document outlines the amount your insurer has offered to pay. Often EOBs list an amount the insurance company did not cover and indicates the amount which may be the patient’s responsibility to pay. However, until you receive a bill directly from KEW, you are not required to make a payment. If not paid at the time of your appointment, you may receive a bill from KEW for co-pays, co-insurance or a deductible.

Do you offer any financial assistance?

If your insurer denies coverage of the test, KEW will work to obtain coverage and will assist in pursuing appeals on your behalf to help minimize the financial burden. The maximum patient payment amount will be determined by your situation and the test ordered. Please call KEW Customer Care at 855.225.4068 for further information.

Non-Medicare patients are also eligible for KEW’s Financial Assistance Program, which can reduce the maximum payment amount further.

If you do not have insurance, or wish to self-pay, please call 855.225.4068 and press 1 for more information about specific policies.

I have more questions about the test, who can I ask?

You can talk with your oncologist or call KEW Customer Care at 855.225.4068 Monday through Friday 7 am – 5:30 pm ET.

Call us




303 Wyman Street, Office #349
Waltham, MA 02451